documents: FDA-2019-D-5473-0017

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-D-5473-0017 FDA FDA-2019-D-5473 Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products Questions and Answers Guidance for Industry; Revised Draft Guidance Other Guidance 2024-04-25T04:00:00Z 2024 4 2024-04-25T04:00:00Z 2024-06-25T03:59:59Z 2025-12-10T20:21:36Z   0 0 09000064864ee8bc

Links from other tables